The estimated Net Worth of Hermanus Kieftenbeld is at least 1.37 百万$ dollars as of 2 June 2023. Mr Kieftenbeld owns over 20,999 units of Amyris Inc stock worth over 10,988$ and over the last 9 years he sold AMRS stock worth over 538,212$. In addition, he makes 817,841$ as CFO & Chief Admin. Officer at Amyris Inc.
Mr has made over 4 trades of the Amyris Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 20,999 units of AMRS stock worth 19,949$ on 2 June 2023.
The largest trade he's ever made was selling 34,905 units of Amyris Inc stock on 2 June 2022 worth over 81,678$. On average, Mr trades about 7,584 units every 46 days since 2016. As of 2 June 2023 he still owns at least 219,768 units of Amyris Inc stock.
You can see the complete history of Mr Kieftenbeld stock trades at the bottom of the page.
Hermanus Kieftenbeld is the CFO & Chief Admin. Officer at Amyris Inc.
As the CFO & Chief Admin. Officer of Amyris Inc, the total compensation of Mr Kieftenbeld at Amyris Inc is 817,841$. There are 4 executives at Amyris Inc getting paid more, with John G. Melo having the highest compensation of 1,344,913$.
Mr Kieftenbeld is 55, he's been the CFO & Chief Admin. Officer of Amyris Inc since . There are 12 older and 7 younger executives at Amyris Inc. The oldest executive at Amyris Inc is Patrick Yang, 72, who is the Independent Director.
Hermanus's mailing address filed with the SEC is 259 Prospect Plains Rd, Cranbury, NJ 08512, USA.
Over the last 14 years, insiders at Amyris Inc have traded over 118,642,007$ worth of Amyris Inc stock and bought 100,049,915 units worth 258,812,433$ . The most active insiders traders include Gas & Power Usa, Sas Total、L John Doerr、Philippe Boisseau. On average, Amyris Inc executives and independent directors trade stock every 25 days with the average trade being worth of 65,903$. The most recent stock trade was executed by Hermanus Kieftenbeld on 2 June 2023, trading 20,999 units of AMRS stock currently worth 19,949$.
amyris is the integrated renewable products company that is enabling the world’s leading brands to achieve sustainable growth. amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. the company is delivering its no compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. more information about the company is available at www.amyris.com.
Amyris Inc executives and other stock owners filed with the SEC include: